A Phase II Study of Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma.
Phase of Trial: Phase II
Latest Information Update: 26 May 2018
At a glance
- Drugs Aflibercept (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Nov 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.